Protein Sciences was founded in 1983 and has over 30 years of experience in developing vaccines and biopharmaceuticals for the prevention and treatment of a variety of diseases. We use our proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost. We have developed three main business lines that employ this technology:
1. Proprietary vaccines - we develop and produce the next generation of safer and more effective vaccines
2. GeneXpress product development and manufacturing services - we partner with others to develop and manufacture modern vaccines, therapeutics and gene therapies
3. Research antigens - we offer a variety of high quality purified antigens and antibodies to the scientific community for disease research
To save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals.
Our values are core to our culture and guide our every action.
Manon M. J. Cox
Transition Taskforce Leader
Dr. Manon M.J. Cox, MBA has been President and Chief Executive Officer since April 2010, a Director since 2008, and is a member of the Nominating Committee. She joined Protein Sciences in 1998 as Director of Business Development and became Chief Operating Officer in 2003. She serves on the Scientific Advisory Boards of Pall BioPharmaceuticals and iCubed, the Board of Directors of United Way, Meriden & Wallingford, and the Netherlands-America Foundation and its Education Committee. Previously she was with Gist-brocades, a large Dutch company specialized in fermentation, where she held various management positions, most recently in New Business Development and before that in Production and Research and Development. Prior to joining Gist-brocades, she worked as a Molecular Biologist on the development of a PCR screening test for cervical cancer at the University of Amsterdam. Dr. Cox has received many honors and awards recognizing her stature as a leader in innovation and influenza, including in 2014 receiving a Doctorate in Humane Letters honoris causa from St. Joseph University and the Woman of Innovation award from the Connecticut Technology Council. Dr. Cox holds a Doctorate from the University of Wageningen, received her MBA with distinction from the University of Nijenrode and the University of Rochester, NY and holds a Doctorandus degree in Molecular Biology, Genetics and Biochemistry from the University of Nijmegen, The Netherlands.
Daniel D. Adams
Head of Business Development
Mr. Adams joined Protein Sciences as CEO in 1996. Prior to that time, he founded and managed biopharmaceutical companies that have a combined market value of over $60 billion. Mr. Adams co-founded Biogen (OTC:BGEN) in 1976 and served as its first President and CEO. He also was Founder and CEO of Advanced Genetic Sciences Inc. (OTC:AGSI) in 1980, was Co-founder and Managing Director of Plant Genetic Systems in 1982, and was Founder and CEO of AlleRx in 1989. Mr. Adams is currently a Director of Medivation Inc. and several private companies and medical schools. He received a B.A. from Cornell University (Chemistry and Physics) and earned his J.D., magna cum laude, from New York University School of Law.
Lisa M. Dunkle
Chief Medical Officer
Dr. Dunkle joined Protein Sciences as Chief Medical Officer in 2011 after a 20+ year career in the pharmaceutical industry. As Executive Director of Clinical Research, she previously headed teams at Bristol-Myers Squibb, Schering-Plough and Merck that developed and brought to market several cutting-edge antiviral agents for HIV and HBV. Prior to joining the pharmaceutical industry, Dr. Dunkle was Professor of Pediatrics and Microbiology and Chief of Infectious Diseases at St. Louis University School of Medicine. She has a B.A. in Biological Sciences from Wellesley College and an M.D. from The Johns Hopkins University School of Medicine. She completed post-doctoral work in Pediatrics and Infectious Diseases at Washington University School of Medicine.
Timothy J. Fields
Senior VP, Quality
Mr. Fields joined Protein Sciences in 2010 as Director of Compliance and Training, and subsequently served as Senior Director of Quality Operations before becoming VP of Quality and Validation in 2011. He has more than 30 years of experience in the pharmaceutical industry, including more than 13 years at Pfizer and 16 years as a GMP compliance consultant. Mr. Fields has experience in a variety of compliance areas, including quality systems, validation, aseptic processing, computerized system validation, GMP training, 21CFR Part 11, document management and auditing. He is a member of PDA and ISPE and is on the editorial review board for the Journal of Validation and Journal of GXP Compliance. Previously, he was a member of DIA, RAPS and ASQC and was an adjunct instructor at the Community College of Rhode Island. He has a B.A. in Biology from Indiana University and an M.A. in Life Sciences from Indiana State University.
Mireli W. Fino
Senior VP, Manufacturing Operations
Ms. Fino joined Protein Sciences in 2012 as VP, Manufacturing Operations. She comes from Wyeth (now Pfizer) where she spent the past 20 years in various roles in vaccine development and commercial manufacturing, most recently as Director Manufacturing Sciences and Technology - Drug Substance. She played a key role in the successful development and launch of Prevnar13® pneumococcal 13-valent conjugate vaccine, considered one of the most complex biologics licensed to date. In addition, Ms. Fino led global initiatives implementing process and yield improvements based on the successful applications of risk management and Quality by Design (QbD) and Process Analytical Technology (PAT) concepts. She has a B.S. in Biochemical Engineering from the University of Aguascalientes in Mexico.
Wayne E. Hachey
Head, Government and Clinical Affairs
Wayne Hachey, DO (Colonel, U.S. Army, ret.) is a physician who has dedicated 28 years of service to the military healthcare system, including six years as a subject matter expert advising senior Department of Defense (DoD) leadership regarding the DoD's vaccine policy. He was also responsible for developing the overarching DoD mitigation response to pandemic influenza and directed the implementation of that policy during the 2009 H1N1 pandemic. Most recently, Dr. Hachey served as the Chief of Public Health for the 1st Medical Brigade in Afghanistan, where he provided public health leadership to protect more than 98,000 U.S. troops. Dr. Hachey has a B.A. in Biology from Fitchburg State College, a B.S.N. in Nursing from Boston College, an M.S. in Pediatric Nursing from University of Wisconsin-Madison, an M.P.H. from Uniformed University of the Health Sciences, and a D.O. from Southeastern College of Osteopathic Medicine. He is board certified in Public Health, Pediatrics and Neonatal-Perinatal Medicine and has won numerous awards, including the Defense Meritorious Service Medal, Meritorious Service Medal, NATO (Afghanistan) and Afghanistan Campaign Medal and Unit Combat Patch.
Penny L. Post
Vice President, Regulatory
Dr. Post joined Protein Sciences Corporation in 2000 and has served in various management roles in Process Development, Quality and Manufacturing, becoming Vice President of Regulatory and Quality in 2007 and Vice President of Regulatory in 2011. She has a strong background in biochemistry and protein purification and has been involved in the development, manufacturing, product release and regulatory filing for recombinant proteins involved in various diseases, such as influenza and AIDS. Prior to joining Protein Sciences Corporation, Dr. Post was a Postdoctoral Fellow and Associate Research Scientist at Yale University. She has a B.A. in Biology from Middlebury College, VT and a Ph.D. in Cell Biology and Biochemistry from Carnegie Mellon University.
Indresh K. Srivastava
Vice President, Product Realization
Dr. Srivastava joined Protein Sciences in 2012 as Vice President, Product Realization. He has a strong background in vaccine development, particularly in immunogen design, purification, analytical and formulation development, and has published extensively in these areas. Dr. Srivastava served on the NIH special emphasis study section focused on vaccine development for ten years, and in 2011 he co-edited the book, "Development of Vaccines: From Discovery to Clinical Testing." Previously, Dr. Srivastava spent more than twelve years at Chiron Corporation/Novartis Vaccines and Diagnostics, Inc. in various capacities, including Head (AI), Protein Biochemistry; Head, Vaccine Manufacturing; and Head, Protein Expression and Analytics. He also spent about two years at the Vaccine Research Center, a division of the National Institute of Allergy and Infectious Diseases, where he led the purification, analytical and formulation development of vaccine candidates for clinical evaluation. Prior to joining the biotechnology industry, Dr. Srivastava was an Assistant Professor of Research in Microbiology and Immunology at the Medical College of Pennsylvania. He holds a Ph.D. from the Kanpur University, India and completed his post-doctoral training with Prof. Luc Perrin at the Hospital Cantonal, University of Geneva, Switzerland.
Nadine Francis West
Senior Vice President, Chief Administrative Officer and Corporate Secretary
Ms. West joined Protein Sciences in 2014 as Senior Vice President, Chief Administrative Officer and Corporate Secretary. Previously, she served as Vice President, Chief Administrative Officer and Corporate Secretary and led the Finance and Administration Team of the MetroHartford Alliance. Prior to joining the Alliance, Ms. West served in the administration of former Hartford Mayor Michael Peters and practiced law in the corporate law department of Aetna, Inc. She is a member of the Executive Committee and Chair of the HR/Compensation Committee of the Hartford Stage Company, a Board Member of the UConn Foundation and Achieve Hartford!, a local education fund. Ms. West serves as an overseer of the Bushnell Performing Arts Center and is a Corporator of both Hartford Hospital and Saint Francis Hospital and Medical Center. She is also the interim President of the Board of Upper Albany Main Street. Ms. West was Vice Chair of the Board and Chair of the Development Committee of the Aurora Women and Girls Foundation, Inc. She has also served as Vice Chair of the Board of Directors and Co-Chair of Development of the YWCA for the Hartford Region. Ms. West is a graduate of the U.S. Chamber's Institute of Organization Management and a 2009 Fellow of the Ford Foundation and American Chamber of Commerce Fellowship for Regional and Sustainable Development. She received a BA from SUNY Stony Brook and a JD from the University of Connecticut and is admitted to the Connecticut Bar.